Top

Published in:

01-07-2022

Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints

Authors: Kete M. Klaver, Saskia F. A. Duijts, Chantal A. V. Geusgens, Maureen J. B. Aarts, Rudolf W. H. M. Ponds, Allard J. van der Beek, Sanne B. Schagen

Published in: Journal of Cancer Survivorship | Issue 2/2024

Abstract

Purpose

To assess cognitive functioning in occupationally active non-central nervous system cancer survivors with cognitive complaints using neuropsychological tests, and to investigate the association between (1) formally assessed cognitive functioning and self-reported work-related outcomes and (2) self-reported cognitive functioning at work and self-reported work-related outcomes.

Methods

Baseline data of a multicenter, randomized controlled trial (n = 279) were used. Associations between neuropsychological test performance (Amsterdam Cognition Scan) and self-reported cognitive functioning (Cognitive Symptom Checklist-work) with work ability (Work Ability Index) and work functioning (Work Role Functioning Questionnaire) were examined using multivariate linear regression.

Results

Thirty percent of cancer survivors had lower than expected performance on neuropsychological tests. Higher overall neuropsychological test performance was associated with better work ability (Cohen’s f² = 0.014) and physical functioning at work (Cohen’s f² = 0.13). Furthermore, higher motor performance was associated with better work ability (Cohen’s f² = 0.018). In addition, self-reported work-related cognitive complaints were associated with self-reported work-related outcomes (Cohen’s f² = 0.13–0.35).

Conclusions

The percentage of cancer survivors with lower than expected performance on neuropsychological tests exceeded the percentage expected in a normal population. This neuropsychological test performance was weakly associated with various aspects of work ability and work functioning. Stronger associations were found between self-reported cognitive functioning at work with self-reported work-related outcomes.

Implications for cancer survivors.

A cognitive rehabilitation approach that specifically aims at reducing cognitive symptoms at work could be a valuable part of interventions that aim to improve work-related outcomes.

Trial registration

The study is registered at ClinicalTrials.gov (NCT03900806) at 03 April 2019 (current status: ongoing), https://clinicaltrials.gov/ct2/show/NCT03900806?term=NCT03900806&draw=2&rank=1

Available only for authorised users

Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA a cancer journal for clinicians. 2015;65:123–38. https://doi.org/10.3322/caac.21258.CrossRefPubMed

Ahles TA, Root JC. Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol. 2018. https://doi.org/10.1146/annurev-clinpsy-050817-084903.CrossRefPubMedPubMedCentral

Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int rev psychiatry (Abingdon, England). 2014;26:102–13. https://doi.org/10.3109/09540261.2013.864260.CrossRefPubMedCentral

Schagen SB et al. Monitoring and optimising cognitive function in cancer patients: present knowledge and future directions. EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] 12, 29–40, https://doi.org/10.1016/j.ejcsup.2014.03.003 (2014).

Mayo SJ, et al. Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020. https://doi.org/10.1007/s00520-020-05860-9.CrossRefPubMed

Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response. Journal of cancer survivorship : research and practice. 2009;3:223–32. https://doi.org/10.1007/s11764-009-0098-x.CrossRefPubMed

Hardy SJ, Krull KR, Wefel JS, Janelsins M. Cognitive changes in cancer survivors. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2018;38:795–806. https://doi.org/10.1200/edbk_201179.CrossRef

Harrison RA, Wefel JS. Neurocognitive function in adult cancer patients. Neurol Clin. 2018;36:653–74. https://doi.org/10.1016/j.ncl.2018.04.014.CrossRefPubMed

Duijts SF, Kieffer JM, van Muijen P, van der Beek AJ. Sustained employability and health-related quality of life in cancer survivors up to four years after diagnosis. Acta Oncol. 2017;56:174–82. https://doi.org/10.1080/0284186X.2016.1266083.CrossRefPubMed

10.

de Boer AG. The European Cancer and Work Network: CANWON. J Occup Rehabil. 2014;24:393–8. https://doi.org/10.1007/s10926-013-9474-5.CrossRefPubMed

11.

de Boer A, et al. Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2015. https://doi.org/10.1002/14651858.CD007569.pub3.CrossRefPubMedPubMedCentral

12.

Von Ah D, et al. Cancer, cognitive impairment, and work-related outcomes: an integrative review. Oncol Nurs Forum. 2016;43:602–16. https://doi.org/10.1188/16.ONF.602-616.CrossRefPubMed

13.

de Boer AG, et al. Long-term work retention after treatment for cancer: a systematic review and meta-analysis. Journal of cancer survivorship : research and practice. 2020;14:135–50. https://doi.org/10.1007/s11764-020-00862-2.CrossRefPubMed

14.

Mehnert A, de Boer A, Feuerstein M. Employment challenges for cancer survivors. Cancer. 2013;119(Suppl 11):2151–9. https://doi.org/10.1002/cncr.28067.CrossRefPubMed

15.

Tamminga SJ, et al. Factors associated with an adverse work outcome in breast cancer survivors 5–10 years after diagnosis: a cross-sectional study. (2019);13, 108–116, https://doi.org/10.1007/s11764-018-0731-7.

16.

Bijker R, et al. Functional impairments and work-related outcomes in breast cancer survivors: a systematic review. J Occup Rehabil. 2018;28:429–51. https://doi.org/10.1007/s10926-017-9736-8.CrossRefPubMed

17.

Von Ah D, Storey S, Crouch A. Relationship between self-reported cognitive function and work-related outcomes in breast cancer survivors. J Cancer Surviv. 2018;12:246–55.CrossRef

18.

Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77:109–30. https://doi.org/10.1016/j.critrevonc.2010.01.004.CrossRefPubMed

19.

Von Ah D, Crouch A. Relationship of perceived everyday cognitive function and work engagement in breast cancer survivors. Support Care Cancer. 2021. https://doi.org/10.1007/s00520-020-05950-8.CrossRefPubMedPubMedCentral

20.

Lange M, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Annals of oncology : official journal of the European Society for Medical Oncology. 2019;30:1925–40. https://doi.org/10.1093/annonc/mdz410.CrossRefPubMed

21.

Nieuwenhuijsen K, de Boer A, Spelten E, Sprangers MA, Verbeek JH. The role of neuropsychological functioning in cancer survivors’ return to work one year after diagnosis. Psychooncology. 2009;18:589–97. https://doi.org/10.1002/pon.1439.CrossRefPubMed

22.

Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med. 2010;52:219–27. https://doi.org/10.1097/JOM.0b013e3181d0bef7.CrossRefPubMed

23.

Klaver K, et al. Internet-based cognitive rehabilitation for WORking Cancer survivors (i-WORC): study protocol of a randomized controlled trial. Trials. 2020;21:664. https://doi.org/10.1186/s13063-020-04570-1.CrossRefPubMedPubMedCentral

24.

Feenstra HEM, Murre JMJ, Vermeulen IE, Kieffer JM, Schagen SB. Reliability and validity of a self-administered tool for online neuropsychological testing: The Amsterdam Cognition Scan. J Clin Exp Neuropsychol, (2017); 1–21, https://doi.org/10.1080/13803395.2017.1339017.

25.

Feenstra HE, Vermeulen IE, Murre JM, Schagen SB. Online self-administered cognitive testing using the Amsterdam cognition scan: establishing psychometric properties and normative data. J Med Internet Res. 2018;20:e192. https://doi.org/10.2196/jmir.9298.CrossRefPubMedPubMedCentral

26.

Tuomi K, Ilmarinen J, Jahkola A, Katajarinne L, Tulkki A. Work ability index. (Institute of Occupational Health Helsinki, 1994).

27.

Ahlstrom L, Grimby-Ekman A, Hagberg M, Dellve L. The work ability index and single-item question: associations with sick leave, symptoms, and health–a prospective study of women on long-term sick leave. Scand J Work Environ Health. 2010;36:404–12.CrossRefPubMed

28.

El Fassi M, et al. Work ability assessment in a worker population: comparison and determinants of Work Ability Index and Work Ability score. BMC Public Health. 2013;13:305. https://doi.org/10.1186/1471-2458-13-305.CrossRefPubMedPubMedCentral

29.

Abma FI, van der Klink JJ, Bultmann U. The work role functioning questionnaire 2.0 (Dutch version): examination of its reliability, validity and responsiveness in the general working population. J occup rehabil. 2013;23:135–47. https://doi.org/10.1007/s10926-012-9379-8.CrossRefPubMed

30.

Dorland HF, et al. Work functioning trajectories in cancer patients: results from the longitudinal Work Life after Cancer (WOLICA) study. Int J Cancer. 2017;141:1751–62. https://doi.org/10.1002/ijc.30876.CrossRefPubMed

31.

Dorland HF, et al. The Cognitive Symptom Checklist-Work in cancer patients is related with work functioning, fatigue and depressive symptoms: a validation study. J cancer survivorship : res pract. 2016;10:545–52. https://doi.org/10.1007/s11764-015-0500-9.CrossRef

32.

Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12:703–8. https://doi.org/10.1016/s1470-2045(10)70294-1.CrossRefPubMed

33.

Leys C, Ley C, Klein O, Bernard P, Licata L. Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol. 2013;49:764–6.CrossRef

34.

Selya AS, Rose JS, Dierker LC, Hedeker D, Mermelstein RJ. A practical guide to calculating Cohen’s f(2), a measure of local effect size, from PROC MIXED. Front Psychol. 2012;3:111. https://doi.org/10.3389/fpsyg.2012.00111.CrossRefPubMedPubMedCentral

35.

Ahles TA, Root JC. Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol. 2018;14:425–51. https://doi.org/10.1146/annurev-clinpsy-050817-084903.CrossRefPubMedPubMedCentral

36.

Vardy JL, Dhillon HM. “Mind the gaps”: cognition and cancer. Psychooncology. 2018;27:10–2. https://doi.org/10.1002/pon.4582.CrossRefPubMed

37.

Cerulla Torrente N, Navarro Pastor JB, de la OsaChaparro N. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy. J cancer survivorship : res pract. 2020;14:464–82. https://doi.org/10.1007/s11764-020-00870-2.CrossRef

38.

Hardy SJ, Krull KR, Wefel JS, Janelsins M. Cognitive changes in cancer survivors. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, (2018); 795–806, https://doi.org/10.1200/edbk_201179.

39.

Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292–9. https://doi.org/10.1002/cncr.20272.CrossRefPubMed

40.

Duijts SF, et al. Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review. Psychooncology. 2014;23:481–92. https://doi.org/10.1002/pon.3467.CrossRefPubMed

41.

Paalman CH, et al. Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study. Br J Cancer. 2016;114:81–7. https://doi.org/10.1038/bjc.2015.431.CrossRefPubMedPubMedCentral

42.

Boscher C, et al. Perceived cognitive impairment in breast cancer survivors and its relationships with psychological factors. Cancers (Basel) (2020);12, https://doi.org/10.3390/cancers12103000.

43.

Wolvers MDJ, Leensen MCJ, Groeneveld IF, Frings-Dresen MHW, De Boer A. Longitudinal associations between fatigue and perceived work ability in cancer survivors. J Occup Rehabil. 2019;29:540–9. https://doi.org/10.1007/s10926-018-9814-6.CrossRefPubMed

44.

Von Ah D, et al. Relationship of self-reported attentional fatigue to perceived work ability in breast cancer survivors. Cancer Nurs. 2017;40:464–70. https://doi.org/10.1097/ncc.0000000000000444.CrossRefPubMed

45.

Dorland HF, et al. Fatigue and depressive symptoms improve but remain negatively related to work functioning over 18 months after return to work in cancer patients. J cancer survivorship : res pract. 2018;12:371–8. https://doi.org/10.1007/s11764-018-0676-x.CrossRef

46.

Markovic C, Mackenzie L, Lewis J, Singh M. Working with cancer: A pilot study of work participation among cancer survivors in Western Sydney. Aust Occup Ther J. 2020;67:592–604. https://doi.org/10.1111/1440-1630.12685.CrossRefPubMed

47.

Horsboel TA, et al. Are fatigue, depression and anxiety associated with labour market participation among patients diagnosed with haematological malignancies? A prospective study Psychooncology. 2015;24:408–15. https://doi.org/10.1002/pon.3658.CrossRefPubMed

48.

49.

van Muijen P, Duijts SF, Bonefaas-Groenewoud K, van der Beek AJ, Anema JR. Factors associated with work disability in employed cancer survivors at 24-month sick leave. BMC Cancer. 2014;14:236. https://doi.org/10.1186/1471-2407-14-236.CrossRefPubMedPubMedCentral

50.

Boelhouwer IG, Vermeer W, van Vuuren T. Late effects of cancer (treatment) and work ability: guidance by managers and professionals. BMC Public Health. 2021;21:1255. https://doi.org/10.1186/s12889-021-11261-2.CrossRefPubMedPubMedCentral

51.

Von Ah D, Jansen C, Allen DH, Schiavone RM, Wulff J. Putting evidence into practice: evidence-based interventions for cancer and cancer treatment-related cognitive impairment. Clin J Oncol Nurs. 2011;15:607–15. https://doi.org/10.1188/11.CJON.607-615.CrossRef

52.

Gehring K, et al. in Cognitive rehabilitation and neuroimaging: examining the evidence from brain to behavior (eds John DeLuca, Nancy D. Chiaravalloti, & Erica Weber) 221–254 (Springer International Publishing, 2020).

Title: Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints
Authors: Kete M. Klaver
Saskia F. A. Duijts
Chantal A. V. Geusgens
Maureen J. B. Aarts
Rudolf W. H. M. Ponds
Allard J. van der Beek
Sanne B. Schagen
Publication date: 01-07-2022
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 2/2024
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-022-01223-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2024

Retirement behavior of cancer survivors: role of health insurance

Forgoing physician visits due to cost: regional clustering among cancer survivors by age, sex, and race/ethnicity

A pilot randomized controlled trial to evaluate a survivorship care planning intervention for head and neck cancer survivor-caregiver dyads

Cancer-related self-perception in men affected by prostate cancer after radical prostatectomy

Caregiver costs and financial burden in caregivers of African American cancer survivors

Reducing rates of chronic breast cancer–related lymphedema with screening and early intervention: an update of recent data

Keynote webinar | Spotlight on antibody–drug conjugates in cancer